{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:01:21Z","timestamp":1791892881698,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.micinf.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T20:15:12Z","timestamp":1501013712000},"page":"496-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Ross River virus disease clinical presentation, pathogenesis and current therapeutic strategies"],"prefix":"10.1016","volume":"19","author":[{"given":"Xiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kothila","family":"Tharmarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2017.07.001_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijid.2017.01.041","article-title":"New evidence for endemic circulation of Ross River virus in the pacific islands and the potential for emergence","volume":"57","author":"Lau","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.micinf.2017.07.001_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/mr.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.micinf.2017.07.001_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0042-6822(88)90474-6","article-title":"Location of a major antigenic site involved in Ross River virus neutralization","volume":"162","author":"Vrati","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2017.07.001_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/viro.2000.0474","article-title":"Characterization of epitopes for virus-neutralizing monoclonal antibodies to Ross River virus E2 using phage-displayed random peptide libraries","volume":"275","author":"Davies","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2017.07.001_bib5","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1128\/JVI.03326-12","article-title":"A\u00a0tyrosine-to-histidine switch at position 18 of the Ross River virus E2 glycoprotein is a determinant of virus fitness in disparate hosts","volume":"87","author":"Jupille","year":"2013","journal-title":"J\u00a0Virol"},{"issue":"8","key":"10.1016\/j.micinf.2017.07.001_bib6","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1128\/JVI.03192-15","article-title":"Effects of an in-frame deletion of the 6k gene locus from the genome of Ross River virus","volume":"90","author":"Taylor","year":"2016","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/icb.1963.2","article-title":"Studies of arthropod-borne virus infections in Queensland. III. Isolation and characterization of virus strains from wild-caught mosquitoes in North Queensland","volume":"41","author":"Doherty","year":"1963","journal-title":"Aust J Exp Biol Med Sci"},{"key":"10.1016\/j.micinf.2017.07.001_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.ento.47.091201.145100","article-title":"Ross River virus: ecology and distribution","volume":"47","author":"Russell","year":"2002","journal-title":"Annu Rev Entomol"},{"key":"10.1016\/j.micinf.2017.07.001_bib9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5694\/j.1326-5377.1985.tb123054.x","article-title":"A\u00a0major outbreak of epidemic polyarthritis in New South Wales during the summer of 1983\/1984","volume":"143","author":"Hawkes","year":"1985","journal-title":"Med J Aust"},{"key":"10.1016\/j.micinf.2017.07.001_bib10","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.31.21200","article-title":"Ross River virus disease in two Dutch travellers returning from Australia, February to April 2015","volume":"20","author":"Reusken","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.micinf.2017.07.001_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5694\/j.1326-5377.2002.tb04836.x","article-title":"Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months","volume":"177","author":"Harley","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.micinf.2017.07.001_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5694\/j.1326-5377.1998.tb116019.x","article-title":"A\u00a0comparison of the diseases caused by Ross River virus and Barmah Forest virus","volume":"169","author":"Flexman","year":"1998","journal-title":"Med J Aust"},{"key":"10.1016\/j.micinf.2017.07.001_bib13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5694\/j.1326-5377.2002.tb04837.x","article-title":"Natural history of Ross River virus-induced epidemic polyarthritis","volume":"177","author":"Mylonas","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.micinf.2017.07.001_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0928-0197(94)00043-3","article-title":"Acute symptoms and sequelae of Ross River virus infection in South-Western Australia: a follow-up study","volume":"3","author":"Condon","year":"1995","journal-title":"Clin Diagn Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib15","first-page":"149","article-title":"Glomerulonephritis in the acute phase of Ross River virus disease (epidemic polyarthritis)","volume":"29","author":"Fraser","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.micinf.2017.07.001_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1445-5994.1999.tb00695.x","article-title":"A\u00a0case of encephalitis in Central Australia due to Ross River virus?","volume":"29","author":"Lucas","year":"1999","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.micinf.2017.07.001_bib17","first-page":"759","article-title":"Persistent arthralgias in ross-river-virus disease after travel to the South Pacific","volume":"124","author":"Proll","year":"1999","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.micinf.2017.07.001_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.bor.0000130537.76808.26","article-title":"Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses","volume":"16","author":"Suhrbier","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.micinf.2017.07.001_bib19","article-title":"Osteoblasts from osteoarthritis patients show enhanced susceptibility to Ross River virus infection associated with delayed type I interferon responses","volume":"11","author":"Chen","year":"2014","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2017.07.001_bib20","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1073\/pnas.1318859111","article-title":"Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss","volume":"111","author":"Chen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2017.07.001_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1128\/CMR.14.4.909-932.2001","article-title":"Ross River virus transmission, infection, and disease: a cross-disciplinary review","volume":"14","author":"Harley","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.micinf.2017.07.001_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/infdis\/127.2.129","article-title":"Pathogenesis of Ross River virus-infection in mice.2. Muscle, heart, and brown fat lesions","volume":"127","author":"Murphy","year":"1973","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2017.07.001_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/315164","article-title":"Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice","volume":"181","author":"Lidbury","year":"2000","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2017.07.001_bib24","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1086\/587841","article-title":"Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus","volume":"197","author":"Lidbury","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2017.07.001_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1128\/JVI.80.2.737-749.2006","article-title":"Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis","volume":"80","author":"Morrison","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib26","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1016\/j.vaccine.2011.03.089","article-title":"Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection","volume":"29","author":"Holzer","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.07.001_bib27","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1128\/JVI.01189-10","article-title":"Identification and characterization of a Ross River virus variant that grows persistently in macrophages, shows altered disease kinetics in a mouse model, and exhibits resistance to type I interferon","volume":"85","author":"Lidbury","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111305","article-title":"Cytokines in acute chikungunya","volume":"9","author":"Venugopalan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2017.07.001_bib29","doi-asserted-by":"crossref","first-page":"10675","DOI":"10.1128\/JVI.00601-12","article-title":"MYD88-dependent toll-like receptor 7 signaling mediates protection from severe Ross River virus-induced disease in mice","volume":"86","author":"Neighbours","year":"2012","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib30","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1128\/JVI.00956-12","article-title":"Interferon response factors 3 and 7 protect against chikungunya virus hemorrhagic fever and shock","volume":"86","author":"Rudd","year":"2012","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cyto.2015.07.003","article-title":"Regulation of type I-interferon responses in the human epidermal melanocyte cell line SKMEL infected by the Ross River alphavirus","volume":"76","author":"Assi","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.micinf.2017.07.001_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.01590-06","article-title":"Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses","volume":"81","author":"Shabman","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib33","doi-asserted-by":"crossref","first-page":"12374","DOI":"10.1128\/JVI.00985-08","article-title":"Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells","volume":"82","author":"Shabman","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib34","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1099\/jgv.0.000412","article-title":"Role of envelope n-linked glycosylation in Ross River virus virulence and transmission","volume":"97","author":"Nelson","year":"2016","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib35","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.02609-13","article-title":"Attenuating mutations in nsp1 reveal tissue-specific mechanisms for control of Ross River virus infection","volume":"88","author":"Stoermer Burrack","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib36","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1073\/pnas.1101089108","article-title":"Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis","volume":"108","author":"Herrero","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2017.07.001_bib37","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/art.38090","article-title":"Macrophage migration inhibitory factor receptor cd74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection","volume":"65","author":"Herrero","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.micinf.2017.07.001_bib38","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.4049\/jimmunol.1101267","article-title":"IFN-gamma promotes muscle damage in the mdx mouse model of duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation","volume":"187","author":"Villalta","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2017.07.001_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/mi.2010.6","article-title":"Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent","volume":"3","author":"Shirey","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.micinf.2017.07.001_bib40","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.4049\/jimmunol.1201240","article-title":"Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus","volume":"189","author":"Stoermer","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2017.07.001_bib41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E","article-title":"Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection","volume":"43","author":"Soden","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.micinf.2017.07.001_bib42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virusres.2016.09.007","article-title":"The growth of arthralgic Ross River virus is restricted in human monocytic cells","volume":"225","author":"Krejbich-Trotot","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.micinf.2017.07.001_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/viro.2002.1587","article-title":"Persistent Ross River virus infection of murine macrophages: an in\u00a0vitro model for the study of viral relapse and immune modulation during long-term infection","volume":"301","author":"Way","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2017.07.001_bib44","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.4049\/jimmunol.0900255","article-title":"Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response","volume":"184","author":"Hoarau","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2017.07.001_bib45","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.1401833","article-title":"CD8+ t cells control Ross River virus infection in musculoskeletal tissues of infected mice","volume":"194","author":"Burrack","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2017.07.001_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.1202177","article-title":"A\u00a0pathogenic role for CD4+ t cells during chikungunya virus infection in mice","volume":"190","author":"Teo","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2017.07.001_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000025023","article-title":"An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8","volume":"43","author":"Mateo","year":"2000","journal-title":"Intervirology"},{"key":"10.1016\/j.micinf.2017.07.001_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004649","article-title":"Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation","volume":"11","author":"Foo","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micinf.2017.07.001_bib49","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1128\/JVI.00224-15","article-title":"Pentosan polysulfate: a novel glycosaminoglycan-like molecule for effective treatment of alphavirus-induced cartilage destruction and inflammatory disease","volume":"89","author":"Herrero","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib50","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1128\/JVI.02799-06","article-title":"Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease","volume":"81","author":"Morrison","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib51","doi-asserted-by":"crossref","first-page":"e1002586","DOI":"10.1371\/journal.ppat.1002586","article-title":"Mannose binding lectin is required for alphavirus-induced arthritis\/myositis","volume":"8","author":"Gunn","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micinf.2017.07.001_bib52","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.4049\/jimmunol.1400752","article-title":"Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression","volume":"193","author":"Banda","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2017.07.001_bib53","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.rhu.0000147052.11190.36","article-title":"Corticosteroid therapy in an alphaviral arthritis","volume":"10","author":"Mylonas","year":"2004","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.micinf.2017.07.001_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10420","article-title":"A\u00a0systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness","volume":"10","author":"Chen","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.micinf.2017.07.001_bib55","article-title":"Chronic rheumatic manifestations following chikungunya virus infection: clinical description and therapeutic considerations","volume":"72","author":"Ribera","year":"2012","journal-title":"Med Trop (Mars)"},{"key":"10.1016\/j.micinf.2017.07.001_bib56","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/art.30112","article-title":"Disease exacerbation by etanercept in a mouse model of alphaviral arthritis and myositis","volume":"63","author":"Zaid","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.micinf.2017.07.001_bib57","first-page":"122","article-title":"Exacerbation of alphaviral arthritis and myositis in a mouse model after etanercept treatment is due to diminished levels of interferon a\/b","volume":"2","author":"Zaid","year":"2013","journal-title":"Virol Mycol"},{"key":"10.1016\/j.micinf.2017.07.001_bib58","doi-asserted-by":"crossref","first-page":"e71146","DOI":"10.1371\/journal.pone.0071146","article-title":"Methotrexate treatment causes early onset of disease in a mouse model of Ross River virus-induced inflammatory disease through increased monocyte production","volume":"8","author":"Taylor","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2017.07.001_bib59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.compbiolchem.2016.06.005","article-title":"Alphavirus protease inhibitors from natural sources: a homology modeling and molecular docking investigation","volume":"64","author":"Byler","year":"2016","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.micinf.2017.07.001_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00693-16","article-title":"Antagonism of the sodium-potassium ATPase impairs chikungunya virus infection","volume":"7","author":"Ashbrook","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.micinf.2017.07.001_bib61","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/art.24682","article-title":"Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins","volume":"60","author":"Rulli","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.micinf.2017.07.001_bib62","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/JVI.02034-14","article-title":"Bindarit, an inhibitor of monocyte chemotactic proteins (mcps) synthesis, protects against bone loss induced by chikungunya virus infection","volume":"89","author":"Chen","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib63","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1099\/vir.0.014209-0","article-title":"Molecular evolutionary dynamics of Ross River virus and implications for vaccine efficacy","volume":"91","author":"Jones","year":"2010","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.micinf.2017.07.001_bib64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CVI.00546-14","article-title":"An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial","volume":"22","author":"Wressnigg","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.micinf.2017.07.001_bib65","doi-asserted-by":"crossref","first-page":"9376","DOI":"10.1016\/j.vaccine.2011.09.125","article-title":"Safety and immunogenicity of an inactivated whole virus vero cell-derived Ross River virus vaccine: a randomized trial","volume":"29","author":"Aichinger","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2017.07.001_bib66","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cell.2015.10.050","article-title":"Broadly neutralizing alphavirus antibodies bind an epitope on e2 and inhibit entry and egress","volume":"163","author":"Fox","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2017.07.001_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01970-16","article-title":"Mutation of the n-terminal region of chikungunya virus capsid protein: implications for vaccine design","volume":"8","author":"Taylor","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.micinf.2017.07.001_bib68","doi-asserted-by":"crossref","first-page":"e3354","DOI":"10.1371\/journal.pntd.0003354","article-title":"Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection","volume":"8","author":"Poo","year":"2014","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457917301144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457917301144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T17:58:37Z","timestamp":1701194317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457917301144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1286457917301144"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2017.07.001","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ross River virus disease clinical presentation, pathogenesis and current therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}